Literature DB >> 16341898

The trans labilization of cis-[PtCl2(13CH3NH2)2] by glutathione can be monitored at physiological pH by [1H,13C] HSQC NMR.

Dan Gibson1, Yonit Kasherman, Dina Kowarski, Inna Freikman.   

Abstract

In order to monitor the trans labilization of cisplatin at physiological pH we have prepared the complex cis-[PtCl(2)((13)CH(3)NH(2))(2)] and studied its interactions with excess glutathione in aqueous solution at neutral pH by two-dimensional [1H,13C] heteronuclear single-quantum correlation (HSQC) NMR spectroscopy. [1H,13C] HSQC spectroscopy is a good method for following the release of (13)CH(3)NH(2) but is not so good for characterizing the Pt species in solution. In the reaction of cisplatin with glutathione, Pt-S bonds are formed and Pt-NH(3) bonds are broken. The best technique for following the formation of Pt-S bonds of cisplatin is by UV spectroscopy. [1H,13C] HSQC spectroscopy is the best method for following the breaking of the Pt-N bonds. [1H,15N] HSQC spectroscopy is the best method for characterizing the different species in solution. However, the intensity of the peaks in the (15)NH(3)-Pt-S region, in [1H,15N] HSQC, reflects a balance between the formation of Pt-S bonds, which increases the signal intensity, and the trans labilization, which decreases the signal intensity. [1H,15N] HSQC spectroscopy and [1H,13C] HSQC spectroscopy are complementary techniques that should be used in conjunction in order to obtain the most accurate information on the interaction of platinum complexes with sulfur-containing ligands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16341898     DOI: 10.1007/s00775-005-0064-7

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  17 in total

1.  Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

Authors:  E R Jamieson; S J Lippard
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

2.  Ring-Opened Adducts of the Anticancer Drug Carboplatin with Sulfur Amino Acids.

Authors:  Kevin J. Barnham; Milos I. Djuran; Piedad del Socorro Murdoch; John D. Ranford; Peter J. Sadler
Journal:  Inorg Chem       Date:  1996-02-14       Impact factor: 5.165

3.  Reactions of cisplatin hydrolytes with methionine, cysteine, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques.

Authors:  M el-Khateeb; T G Appleton; L R Gahan; B G Charles; S J Berners-Price; A M Bolton
Journal:  J Inorg Biochem       Date:  1999-10       Impact factor: 4.155

Review 4.  Recognition of cisplatin adducts by cellular proteins.

Authors:  M Kartalou; J M Essigmann
Journal:  Mutat Res       Date:  2001-07-01       Impact factor: 2.433

5.  Platination of a GG site on single-stranded and double-stranded forms of a 14-base oligonucleotide with diaqua cisplatin followed by NMR and HPLC -- influence of the platinum ligands and base sequence on 5'-G versus 3'-G platination selectivity.

Authors:  F Reeder; Z Guo; P D Murdoch; A Corazza; T W Hambley; S J Berners-Price; J C Chottard; P J Sadler
Journal:  Eur J Biochem       Date:  1997-10-15

Review 6.  The molecular basis of cisplatin sensitivity/resistance.

Authors:  L R Kelland
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

7.  Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs.

Authors:  Peter D Sadowitz; Bradley A Hubbard; James C Dabrowiak; Jerry Goodisman; Kirk A Tacka; Mehmet K Aktas; Mary J Cunningham; Ronald L Dubowy; Abdul-Kader Souid
Journal:  Drug Metab Dispos       Date:  2002-02       Impact factor: 3.922

Review 8.  Cisplatin: from DNA damage to cancer chemotherapy.

Authors:  S M Cohen; S J Lippard
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

Review 9.  Cellular processing of platinum anticancer drugs.

Authors:  Dong Wang; Stephen J Lippard
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

10.  Influence of temperature on platinum binding to DNA, cell killing, and mutation induction in Escherichia coli K-12 cells treated with cis-diamminedichloroplatinum(II).

Authors:  J Brouwer; A M Fichtinger-Schepman; P van de Putte; J Reedijk
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

View more
  5 in total

1.  The trans influence in the modulation of platinum anticancer agent biology: the effect of nitrite leaving group on aquation, reactions with S-nucleophiles and DNA binding of dinuclear and trinuclear compounds.

Authors:  Eva I Montero; Junyong Zhang; Joseph J Moniodis; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chemistry       Date:  2010-08-09       Impact factor: 5.236

2.  Cisplatin handover between copper transporters: the effect of reducing agents.

Authors:  Angela Galliani; Maurizio Losacco; Alessia Lasorsa; Giovanni Natile; Fabio Arnesano
Journal:  J Biol Inorg Chem       Date:  2014-05-01       Impact factor: 3.358

3.  Determination of the kinetic profile of a dinuclear platinum anticancer complex in the presence of sulfate: introducing a new tool for the expedited analysis of 2D [(1)H,( 15)N] HSQC NMR spectra.

Authors:  Rasha A Ruhayel; Ben Corry; Carlos Braun; Donald S Thomas; Susan J Berners-Price; Nicholas P Farrell
Journal:  Inorg Chem       Date:  2010-11-10       Impact factor: 5.165

4.  Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts.

Authors:  Yonit Kasherman; Stefan Sturup; Dan Gibson
Journal:  J Biol Inorg Chem       Date:  2008-12-04       Impact factor: 3.358

5.  Cisplatin interaction with phosphatidylserine bilayer studied by solid-state NMR spectroscopy.

Authors:  Magnus Jensen; Morten Bjerring; Niels Chr Nielsen; Willy Nerdal
Journal:  J Biol Inorg Chem       Date:  2009-09-19       Impact factor: 3.358

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.